Navigation Links
Novel drug candidates offer new route to controlling inflammation
Date:5/14/2012

e complexity of the complement system. In some cases complement activity can help downplay immune responses while in other cases it can stoke even stronger reactions.

The collaborators were able to create peptides that blocked activity of C3a (antagonists) and others that stimulated it (agonists) with unprecedented potency and precision. Their success stems from a novel optimization-based approach, developed in the Floudas lab, for computing how a protein's three-dimensional structure will change when changes are made in the protein's chemical sequence. This ability to design peptides of a desired shape, allowed them to target the C3a receptor in precise ways.

Morikis and his graduate students Chris Kieslich and Li Zhang provided the collaborators the 3D structure of the naturally occurring peptide that normally regulates the C3a receptor in human cells. Using a portion of that structure as a flexible template, Floudas and graduate students Meghan Bellows-Peterson and Ho Ki Fung designed new peptides that were predicted either to enhance or block C3a. Monk and postdoctoral fellow Kathryn Wareham tested the predictions in rat cells, while Woodruff and student Owen Hawksworth tested them in human cells.

Among the conditions potentially treatable through complement regulation is reperfusion injury, which occurs when blood flow is temporarily cut off to some part of the body, as in a heart attack or stroke, and then an inflammatory response develops when the blood returns. Another possible use would be in organ transplantation, in which the body often mounts a destructive immune response against the newly introduced organ. Other common conditions affected by the complement system are rheumatoid arthritis and sepsis.

As next steps, the team will seek to test their peptides in live animal models of inflammation. They also plan to explore more generally the dual role of C3a in inflammation, with an eye toward developing further drug cand
'/>"/>

Contact: Steven Schultz
sschultz@princeton.edu
609-252-1919
Princeton University, Engineering School
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Rutgers team discovers novel approach to stimulate immune cells
2. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
3. Novel drug in pill form safer than standard approach to treat blocked lung blood vessels
4. Novel mouse model for autism yields clues to a 50-year-old mystery
5. Unprecedented academic-industry collaboration seeks new drugs and novel treatments for autism
6. Novel plastics and textiles from waste with the use of microbes
7. UC San Diego among first in nation to treat brain cancer with novel viral vector
8. Students at Western University develop a novel way to teach interdisciplinary care
9. UH Case Medical Center publishes study on novel treatment for skin lymphoma
10. Mass. General researchers find novel way to prevent drug-induced liver injury
11. Rutgers, Massachusetts General investigators find novel way to prevent drug-induced liver injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel drug candidates offer new route to controlling inflammation
(Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... 2015 Autocarinsurancebest.com has released a new blog ... auto insurance policy . , Auto insurance quotes help ... is no longer necessary to call an agent or visit ... online on a single website: http://autocarinsurancebest.com/ . , Every ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... Today the U.S. Senate,passed a crucial bill, backed ... global HIV/AIDS while also authorizing much greater funding ... bill is a tremendous achievement, and I commend ... Senator Reid whose fierce determination,to bring the bill ...
... a,statement by Tom Epstein, Vice President, Public Affairs, Blue ... City Attorney is totally without,merit., The issues raised ... that have aggressively defended the interests of consumers.,In filing ... hot topic in an,attempt to advance his political future., ...
... University, the collective strength of biomedical research and the ... High-End Instrumentation (HEI) grant from the National Institutes of ... a state-of-the-art robotic electron microscope to advance cutting-edge studies ... will have $4.8 million in total funding after it ...
... gastroscopy and post contrast enhanced multiplanar reformation images ... benign gastric ulcers, according to a recent study ... in Kaohsiung, Taiwan. , "Conventional gastroscopy can diagnose ... invasive and occasionally may miss early stage disease. ...
... top scientific,advisors investigate and explain non-drug therapies - ... and neurofeedback -,that may relieve ADHD symptoms in ... and supplements can help treat ADHD symptoms., ... leading,publication for families and adults living with attention ...
... announced today that,it has been re-certified by the ... to earn the Commission,s Gold Seal,of Approval(TM). For ... division: Med Travelers., AMN was the first ... under,the Joint Commission,s corporate certification, having initially earned ...
Cached Medicine News:Health News:Senate Passes Landmark AIDS, TB and Malaria Bill, Says Global AIDS Alliance 2Health News:Senate Passes Landmark AIDS, TB and Malaria Bill, Says Global AIDS Alliance 3Health News:Statement Regarding Los Angeles City Attorney Enforcement Action 2Health News:With $2M NIH grant, FSU becomes 1 of world's top imaging centers 2Health News:With $2M NIH grant, FSU becomes 1 of world's top imaging centers 3Health News:With $2M NIH grant, FSU becomes 1 of world's top imaging centers 4Health News:Treating ADHD Symptoms Without Medication: Free Special Report Examines Alternative ADHD Treatments 2Health News:AMN Healthcare Announces Joint Commission Re-Certification 2
(Date:1/23/2015)... (NYSE: MNK ) announced today that its ... The open-ended authorization permits the company to repurchase up ... "Funding additional initiatives and seeking attractive business ... pursue a range of focused growth strategies," said ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... a focus on Omega-3 therapies for cardiovascular disease and overall ... the Company,s accomplishments in 2014 and its outlook for 2015 ... Dear Fellow Shareholders, We would like to take ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... U.S. Food and Drug Administration has scheduled its fourth ... those unfamiliar with the process for Feb. 28 – ... Keck Graduate Institute. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... Organization of Rare Disorders and the Genetic Alliance, will ...
... /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China ... CSKI ), a leading fully integrated pharmaceutical ... today announced that Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong"), ... a "Top Ten Branded Company Trusted by Consumers" ...
Cached Medicine Technology:Fourth FDA Orphan Drug Designation Workshop Scheduled for Feb. 28 - March 1, 2011 2China Sky One Medical Receives Medical Industry Awards 2China Sky One Medical Receives Medical Industry Awards 3
Unipolar Atrial "J" Lead...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: